Skip to Content
  1. All Products
  2. Biosimilar Antibodies
  3. Gentaur Epcoritamab – Anti-CD3E / CD20 (MS4A1) Bispecific
-
Gentaur Epcoritamab – Anti-CD3E / CD20 (MS4A1) Bispecific

Gentaur Epcoritamab – Anti-CD3E / CD20 (MS4A1) Bispecific

https://www.kineret-eu.com/web/image/product.template/26257/image_1920?unique=58978df
(0 review)
Bridges T-cells to B-cells by binding CD3E and CD20, driving targeted B-cell depletion. Ideal for lymphoma and immunotherapy models.

1,234,567.00 € 1234567.0 EUR 1,234,567.00 € Tax Excluded

1,234,567.00 € Tax Excluded

Not Available For Sale

(0.00 € / Units)

    This combination does not exist.

    Contact Us

    Terms and Conditions
    30-day money-back guarantee
    Shipping: 2-3 Business Days

    Share

    Internal Reference: GMA-CD3E
    Display Name: [GMA-CD3E] Gentaur Epcoritamab – Anti-CD3E / CD20 (MS4A1) Bispecific